Breath-holding spells comorbidity with epileptic seizures in children: VEEG and clinical outcomes

Bo Chen1, Hongjun Fang, Xiaojun Kuang

  • 1Affiliated Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), Changsha, Hunan, China.

Medicine
|November 8, 2025
PubMed

Insights

Breath-holding spells (BHS) can coexist with epileptic seizures (ES) in children. Early diagnosis using electroencephalogram (EEG) and clinical evaluation is crucial for effective management and prognosis.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Neurophysiology

Background:

  • Breath-holding spells (BHS) and epileptic seizures (ES) are distinct neurological conditions in children.
  • Comorbidity between BHS and ES presents diagnostic and therapeutic challenges.
  • Understanding the interplay between BHS and ES is vital for accurate assessment and patient care.

Purpose of the Study:

  • To investigate the electroencephalogram (EEG) and clinical characteristics of children with comorbid BHS and ES.
  • To provide a reference for rational diagnosis and prognosis assessment in these complex cases.
  • To differentiate characteristics between BHS-only and BHS with ES groups.

Main Methods:

  • Prospective analysis of clinical data, EEG, and clinical characteristics of 7 pediatric patients with BHS and ES.
  • Comparison of clinical and EEG findings between a BHS-only group and a BHS+ES group.
  • Analysis of ictal and interictal EEG patterns, seizure types, treatment responses, and associated comorbidities.

Main Results:

  • BHS and ES occurred successively or simultaneously in the studied patients.
  • EEG revealed characteristic 'slow' and 'slow-flat-slow' patterns during BHS.
  • The BHS+ES group showed higher rates of head MRI abnormalities, abnormal EEGs, and developmental delay compared to the BHS-only group.

Conclusions:

  • BHS can coexist with ES in children, particularly those with neurological abnormalities.
  • Diagnosis requires a combination of clinical manifestations and video-EEG (VEEG) monitoring.
  • Timely EEG evaluation is essential if new seizure forms emerge in BHS patients to identify ES and guide treatment.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
802
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
258
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
355
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
404